Drug developer City Therapeutics files for US IPO as biotech listings surge 

4

Sept 24 (Reuters) – Drug developer City Therapeutics filed for a US initial public offering on Thursday, joining a rush of biotech firms lining up to tap the fall IPO window.  Biotech has been one of

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)